| Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy, PK Rambarat, ... Circulation 142 (24), 2299-2311, 2020 | 321 | 2020 |
| Myocardial T1 and T2 mapping by magnetic resonance in patients with immune checkpoint inhibitor–associated myocarditis P Thavendiranathan, L Zhang, A Zafar, ZD Drobni, SS Mahmood, ... Journal of the American College of Cardiology 77 (12), 1503-1516, 2021 | 119 | 2021 |
| Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines CA Gongora, ZD Drobni, T Quinaglia Araujo Costa Silva, A Zafar, J Gong, ... Heart Failure 10 (8), 559-567, 2022 | 47 | 2022 |
| Immune checkpoint inhibitors for cancer and venous thromboembolic events J Gong, ZD Drobni, RM Alvi, SP Murphy, RJ Sullivan, SE Hartmann, ... European Journal of Cancer 158, 99-110, 2021 | 46 | 2021 |
| Decreased absolute lymphocyte count and increased neutrophil/lymphocyte ratio with immune checkpoint inhibitor–associated myocarditis ZD Drobni, A Zafar, L Zubiri, DA Zlotoff, RM Alvi, C Lee, S Hartmann, ... Journal of the American Heart Association 9 (23), e018306, 2020 | 44 | 2020 |
| Electrocardiographic features of immune checkpoint inhibitor associated myocarditis DA Zlotoff, MZO Hassan, A Zafar, RM Alvi, M Awadalla, SS Mahmood, ... Journal for immunotherapy of cancer 9 (3), 2021 | 43 | 2021 |
| Pericardial disease in patients treated with immune checkpoint inhibitors J Gong, ZD Drobni, A Zafar, T Quinaglia, S Hartmann, HK Gilman, ... Journal for immunotherapy of cancer 9 (6), 2021 | 42 | 2021 |
| The incidence, risk factors, and outcomes with 5-fluorouracil–associated coronary vasospasm A Zafar, ZD Drobni, R Mosarla, RM Alvi, M Lei, UY Lou, VK Raghu, ... Cardio Oncology 3 (1), 101-109, 2021 | 41 | 2021 |
| Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial TG Neilan, T Quinaglia, T Onoue, SS Mahmood, ZD Drobni, HK Gilman, ... JAMA 330 (6), 528-536, 2023 | 37 | 2023 |
| Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors ZD Drobni, O Michielin, T Quinaglia, DA Zlotoff, L Zubiri, HK Gilman, ... European Journal of Cancer 163, 108-118, 2022 | 22 | 2022 |
| The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm A Zafar, ZD Drobni, M Lei, CA Gongora, T Quinaglia, UY Lou, R Mosarla, ... PLoS One 17 (4), e0265767, 2022 | 11 | 2022 |
| Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy C Lee, ZD Drobni, A Zafar, CA Gongora, DA Zlotoff, RM Alvi, J Taron, ... Cardio Oncology 4 (5), 660-669, 2022 | 10 | 2022 |
| Global circumferential and radial strain among patients with immune checkpoint inhibitor myocarditis T Quinaglia, C Gongora, M Awadalla, MZO Hassan, A Zafar, ZD Drobni, ... Cardiovascular Imaging 15 (11), 1883-1896, 2022 | 10 | 2022 |
| Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors ZD Drobni, SP Murphy, RM Alvi, C Lee, J Gong, RC Mosarla, ... Immunotherapy Advances 1 (1), ltab014, 2021 | 7 | 2021 |
| Serial measurement of global longitudinal strain among women with breast cancer treated with proton radiation therapy: A prospective trial for 70 patients MZO Hassan, M Awadalla, TC Tan, M Scherrer-Crosbie, RB Bakar, ... International Journal of Radiation Oncology* Biology* Physics 115 (2), 398-406, 2023 | 5 | 2023 |
| Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer ZD Drobni, C Gongora, J Taron, GA Suero-Abreu, J Karady, HK Gilman, ... Journal for ImmunoTherapy of Cancer 11 (7), 2023 | 5 | 2023 |
| Effect Of tocilizumab on cardiac injury and dysfunction in COVID-19 A Zafar, J Khambhati, Z Drobni, C Gongora, NK Horick, A Foulkes, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 3028-3028, 2021 | 3 | 2021 |
| The prediction of cardiac events using contemporary risk prediction models after radiation therapy for head and neck cancer RM Alvi, T Quinaglia, A Spahillari, GA Suero-Abreu, MZO Hassan, ... Cancers 14 (15), 3651, 2022 | 2 | 2022 |
| Immune checkpoint inhibitors for cancer are associated with increased venous thromboembolism events J Gong, Z Drobni, R Alvi, S Murphy, S Hartmann, H Gilman, L Zubiri, ... Circulation 142 (Suppl_3), A15395-A15395, 2020 | 1 | 2020 |
| Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP R Nemec, M Scherrer-Crosbie, JS Abramson, R Redd, HK Gilman, T Ho, ... Leukemia & Lymphoma, 1-6, 2024 | | 2024 |
